Evaluation of the Quantum II yeast identification system
- 1 August 1985
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 22 (2) , 216-219
- https://doi.org/10.1128/jcm.22.2.216-219.1985
Abstract
Three methods for identifying clinical yeast isolates were compared: Abbott Quantum II, API 20C and a modified BBL Minitek system. The API 20C and modified Minitek systems agreed on the identification of 243 of 245 yeasts (99.2%). The Quantum II system correctly identified 197 (80.4%), incorrectly identified 19 (7.8%) and did not identify 29 (11.8%) of the yeasts. Most of the misidentifications with the Quantum II occurred because assimilation or biochemical results were false-positive; 16 different species of yeasts and 16 different Quantum II substrates contributed to the discrepancies. On retesting with the Quantum II, 31% of the discrepant strains were correctly identified, while the remaining 69% were incorrectly identified or were not identified. Erroneous biochemical and assimilation results were also noted with yeasts that were correctly identified by the Quantum II system.This publication has 9 references indexed in Scilit:
- Collaborative evaluation of the Abbott yeast identification systemJournal of Clinical Microbiology, 1984
- Fungemia in the immunocompromised hostThe American Journal of Medicine, 1981
- The Prevalence of Yeasts in Clinical Specimens from Cancer PatientsAmerican Journal of Clinical Pathology, 1980
- Evaluation of the new API 20C strip for yeast identification against a conventional methodJournal of Clinical Microbiology, 1979
- Evaluation of the modified API 20C system for identification of clinically important yeastsJournal of Clinical Microbiology, 1979
- Further modifications of the auxanographic method for identification of yeastsJournal of Clinical Microbiology, 1977